Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych MEQs / SAQsIntellectual disability psychiatry — genetic syndromes

Psych MEQs / SAQs · Intellectual disability psychiatry — genetic syndromes

Behavioural phenotypes and genetic syndromes (MEQ)

FRANZCP-style MEQ covering probabilistic behavioural phenotypes, 22q11.2DS/VCFS psychosis, comparative syndrome phenotypes, investigations and start-low go-slow antipsychotic principles.

20 marks20 min1 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 19-year-old with mild intellectual disability, repaired tetralogy of Fallot and a history of hypernasal speech presents with 3 months of social withdrawal, second-person auditory hallucinations and persecutory delusions. Mother recalls recurrent hypocalcaemia in childhood. Separately, the consultant asks you to contrast this presentation with behavioural phenotypes of Down syndrome, fragile X, Prader-Willi and Angelman syndromes. (i) Define behavioural phenotype. (ii) What genetic diagnosis is most likely here and what is the approximate adult psychosis risk teaching point? (iii) Outline key behavioural/psychiatric phenotypes of Down, fragile X, PWS and Angelman with one genetic mechanism each. (iv) List essential medical investigations and multidisciplinary steps now. (v) State psychopharmacology principles in ID for treating his psychosis. (20 marks)

Model answer

Reveal model answerShowHide

(i) Definition. A behavioural phenotype is the heightened probability that people with a given genetic syndrome will show particular cognitive, social, communicative and psychiatric patterns. Features are neither universal nor exclusive and do not replace a DSM/ICD psychiatric diagnosis.[1]

(ii) Likely diagnosis and risk. 22q11.2 deletion syndrome (VCFS/DiGeorge spectrum): conotruncal heart disease, palatal speech issues, hypocalcaemia history, ID and new psychosis. Adult schizophrenia-spectrum rates are very high in landmark VCFS work (Murphy) and consortium data support substantial psychosis risk into adulthood — longitudinal psychiatric care is mandatory.[2][3][4]

(iii) Comparative phenotypes. Down syndrome (trisomy 21): depression and early Alzheimer dementia risk with age; medical confounders common. Fragile X (FMR1 full mutation, typically greater than 200 CGG): ID, ASD features, ADHD, anxiety; X-linked; premutation relatives may have FXPOI/FXTAS clues. Prader-Willi (loss of paternal 15q11-q13 gene expression): hyperphagia, OCD-like behaviours, temper outbursts; psychosis especially with maternal UPD. Angelman (loss of maternal UBE3A): severe ID, minimal speech, seizures, happy demeanour, ataxia.[5][6][7][8][9]

(iv) Now. Medical: calcium/PTH, ECG, infection screen, substances, metabolic baseline before antipsychotic. Confirm/arrange 22q11.2 genetic documentation (often chromosomal microarray) and clinical genetics. Multisystem review (cardiac, immune, speech). Collateral MSE; risk assessment; capacity and least-restrictive legal status under local law. Early psychosis pathway with ID-adapted communication.[3][4]

(v) Psychopharmacology. Treat clear psychosis with an antipsychotic — start low, go slow in ID (e.g. risperidone oral 0.25–0.5 mg daily initially with slow titration, or alternative with attention to QTc/metabolic risk); monitor weight, glucose/lipids, EPS, prolactin as relevant; check calcium and cardiac status. Do not use antipsychotics as first-line for pure communication-driven behaviour without psychosis. Combine with psychosocial supports and carer education.[3][4]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this meqs / saq. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References9ShowHide
  1. [1]Dykens EM Measuring behavioral phenotypes: provocations from the "new genetics" Am J Ment Retard, 1995.PMID 7779347
  2. [2]Murphy KC, Jones LA, Owen MJ High rates of schizophrenia in adults with velo-cardio-facial syndrome Arch Gen Psychiatry, 1999.PMID 10530637
  3. [3]Schneider M, Debbané M, Bassett AS, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome Am J Psychiatry, 2014.PMID 24577245
  4. [4]Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome J Pediatr, 2011.PMID 21570089
  5. [5]Cassidy SB, Schwartz S, Miller JL, Driscoll DJ Prader-Willi syndrome Genet Med, 2012.PMID 22237428
  6. [6]Boer H, Holland A, Whittington J, et al. Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy Lancet, 2002.PMID 11809260
  7. [7]Hagerman RJ, Berry-Kravis E, Hazlett HC, et al. Fragile X syndrome Nat Rev Dis Primers, 2017.PMID 28960184
  8. [8]Antonarakis SE, Skotko BG, Rafii MS, et al. Down syndrome Nat Rev Dis Primers, 2020.PMID 32029743
  9. [9]Williams CA, Beaudet AL, Clayton-Smith J, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria Am J Med Genet A, 2006.PMID 16470747
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSupportive psychotherapy techniques (MEQ)PsychotherapyNextBenzodiazepine initiation, conversion and taper (MEQ)Psychopharmacology — benzodiazepine prescribing and tapering